IX. IRODALOMJEGYZÉK

  1. Juhasz B, Varga B, Gesztelyi R, Kemeny-Beke A, Zsuga J, Tosaki A. Resveratrol: a multifunctional cytoprotective molecule. Current pharmaceutical biotechnology 2010; 11:810-8.
  2. Moro C, Grauzam S, Ormezzano O, Toufektsian MC, Tanguy S, Calabrese P, et al. Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunction. Journal of cellular and molecular medicine 2011; 15:1688-94.
  3. Juhasz B, Varga B, Czompa A, Bak I, Lekli I, Gesztelyi R, et al. Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium. Journal of cellular and molecular medicine 2011; 15:1973-82.
  4. Bak I, Czompa A, Juhasz B, Lekli I, Tosaki A. Reduction of reperfusion-induced ventricular fibrillation and infarct size via heme oxygenase-1 overexpression in isolated mouse hearts*. Journal of cellular and molecular medicine 2010.
  5. Juhasz B, Der P, Szodoray P, Gesztelyi R, Lekli I, Bak I, et al. Adrenocorticotrope hormone fragment (4-10) attenuates the ischemia/reperfusion-induced cardiac injury in isolated rat hearts. Antioxidants & redox signaling 2007; 9:1851-61.
  6. Thirunavukkarasu M, Juhasz B, Zhan L, Menon VP, Tosaki A, Otani H, et al. VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium. Free radical biology & medicine 2007; 42:1487-95.
  7. Varadi J, Lekli I, Juhasz B, Bacskay I, Szabo G, Gesztelyi R, et al. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery. Life sciences 2007; 80:1619-26.
  8. Bak I, Lekli I, Juhasz B, Nagy N, Varga E, Varadi J, et al. Cardioprotective mechanisms of Prunus cerasus (sour cherry) seed extract against ischemia-reperfusion-induced damage in isolated rat hearts. American journal of physiology Heart and circulatory physiology 2006; 291:H1329-36.
  9. Juhasz B, Der P, Turoczi T, Bacskay I, Varga E, Tosaki A. Preconditioning in intact and previously diseased myocardium: laboratory or clinical dilemma? Antioxidants & redox signaling 2004; 6:325-33.
  10. Vecsernyes M, Juhasz B, Der P, Kocsan R, Feher P, Bacskay I, et al. The administration of alpha-melanocyte-stimulating hormone protects the ischemic/reperfused myocardium. European journal of pharmacology 2003; 470:177-83.
  11. Cui J, Juhasz B, Tosaki A, Maulik N, Das DK. Cardioprotection with grapes. Journal of cardiovascular pharmacology 2002; 0:762-9.
  12. Szalai Z, Szasz A, Nagy I, Puskas LG, Kupai K, Kiraly A, et al. Anti-inflammatory effect of recreational exercise in TNBS-induced colitis in rats: role of NOS/HO/MPO system. Oxid Med Cell Longev 2014; 2014:925981.
  13. Posa A, Kupai K, Menesi R, Szalai Z, Szabo R, Pinter Z, et al. Sexual dimorphism of cardiovascular ischemia susceptibility is mediated by heme oxygenase. Oxid Med Cell Longev 2013; 2013:521563.
  14. Posa A, Nyolczas N, Hemetsberger R, Pavo N, Petnehazy O, Petrasi Z, et al. Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010; 76:395-403.
  15. Posa A, Pavo N, Hemetsberger R, Csonka C, Csont T, Ferdinandy P, et al. Protective effect of ischaemic preconditioning on ischaemia/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs. Thromb Haemost 2010; 103:450-60.
  16. Csonka C, Kupai K, Bencsik P, Gorbe A, Paloczi J, Zvara A, et al. Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K+ channel activators cromakalim and diazoxide. American journal of physiology Heart and circulatory physiology 2014; 306:H405-13.
  17. Bester DJ, Kupai K, Csont T, Szucs G, Csonka C, Esterhuyse AJ, et al. Dietary red palm oil supplementation reduces myocardial infarct size in an isolated perfused rat heart model. Lipids Health Dis 2010; 9:64.
  18. Csonka C, Kupai K, Kocsis GF, Novak G, Fekete V, Bencsik P, et al. Measurement of myocardial infarct size in preclinical studies. Journal of pharmacological and toxicological methods 2010; 61:163-70.
  19. Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, Marais de W, et al. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. American journal of physiology Heart and circulatory physiology 2009; 297:H1729-35.
  20. Kupai K, Szucs G, Cseh S, Hajdu I, Csonka C, Csont T, et al. Matrix metalloproteinase activity assays: Importance of zymography. Journal of pharmacological and toxicological methods 2010; 61:205-9.
  21. Szucs G, Bester DJ, Kupai K, Csont T, Csonka C, Esterhuyse AJ, et al. Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats. Lipids Health Dis 2011; 10:103.
  22. Varga ZV, Kupai K, Szucs G, Gaspar R, Paloczi J, Farago N, et al. MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. Journal of molecular and cellular cardiology 2013; 62:111-21.
  23. Attila F. Az orvosi élettan tankönyve. 2013 ISBN: 978 963 226 464 6
  24. Veronika Á. Orvosi Biokémia. 2006. ISBN 963242967X
  25. Jack H. Wilmore DLC. Physiology of Sport and Exercise. 2004. ISBN:0-7360-4489-2
  26. http://www.tankonyvtar.hu/hu/tartalom/tamop425/0019_1A_Elettani_alapismeretek/ch02.html
  27. Scott K. Power, Edward T. Howley Exercise Physiology ISBN 978-07-337647-9 ISBN:978-963-08-5981-3